Investor Ideas, Trading Ideas and Stocks to Watch : #AIEye #Podcast: #AI #Stocks in the News: (OTCPINK: $GTCH) (NasdaqCM: $BNIX) (NYSE: $IBM)

Tuesday, August 15, 2023

#AIEye #Podcast: #AI #Stocks in the News: (OTCPINK: $GTCH) (NasdaqCM: $BNIX) (NYSE: $IBM)

#AIEye #Podcast: #AI #Stocks in the News: (OTCPINK: $GTCH) (NasdaqCM: $BNIX) (NYSE: $IBM)

GBT Announces Patent Purchase Agreement with Bannix Acquisition Corp. for Apollo IP System, and IBM Brings AI-Powered Features to US Open

Global #AI in #CancerDiagnostics Market to Reach $996.1M by 2030

Vancouver, Kelowna, Delta, BC – August 15, 2023 – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye-watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2023/081523-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2023/artificial-intelligence/08151GTCH-BNIX-IBM.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (OTCPINK:GTCH) (NasdaqCM:BNIX) (NYSE:IBM)

GBT Technologies Inc. (OTC PINK:GTCH) has entered into a definitive Patent Purchase Agreement through its 50 percent-owned GBT Tokenize Corp. with Bannix Acquisition Corp. (NasdaqCM:BNIX) wherein the latter will acquire the Apollo IP system for $42,500,000 payable in shares of Preferred Stock of BNIX. The Apollo IP system is described as “a revolutionary radio frequency-based computer vision technology that, upon full development, can provide autonomous vehicles with superior perception and mapping capabilities in all lighting conditions and weather.” Doug Davis, CEO of Bannix Acquisition Corp., explained:

"We are excited to announce our acquisition agreement with Tokenize. We believe this strategic acquisition will allow us to partner with multiple integrators of autonomous vehicles. We believe it will also enhance our Business Combination partner Evie Autonomous Group's exciting, patent-pending, AI enhanced radar vision system that allows vehicles to perceive their environment, using 4D radar and algorithms to intelligently interpret the sensor data and unlock tremendous value and position us as a leader in the autonomous technology space. Together, we will drive the future of mobility and revolutionize the way people experience transportation.”

IBM (NYSE:IBM) and the United States Tennis Association (USTA) have announced the implementation of AI-powered digital fan features on USOpen.org and the US Open app. This will include AI generated commentary and captions powered by watsonx, IBM's AI and data platform. Jonathan Adashek, Senior Vice President of Communications and Marketing at IBM, explained:

"Fans accessing the US Open digital experiences this year will be able to experience every singles match, across all seventeen courts, with detailed audio narration and captions accompanying each video – thanks to the power of IBM's watsonx generative AI, specifically trained on the language of tennis. The AI Commentary feature was developed based on the watsonx enterprise-ready data and AI platform, designed to enable businesses to accelerate generative AI work by leveraging foundation models and machine learning in one place, with their own data."

Global AI in Cancer Diagnostics Market to Reach $996.1M by 2030

A report published by Research and Markets finds that the global market for AI in Cancer Diagnostics is projected to grow from $137.8 million USD in 2022 to $996.1 million by 2030, registering a compound annual growth rate (CAGR) of 26.3 percent in the forecast period 2023-30. The following excerpt from the report’s description outlines some key factors impacting the growth of the market:

The increasing scope of applications of artificial intelligence (AI) in various healthcare fields, including diagnostics; the rising prevalence of cancer; and the growing shortage of public health workforce are some of the key factors anticipated to fuel the adoption of artificial intelligence (AI) in cancer diagnostics over the forecast period. In addition, the increasing applicability of AI-based tools in cancer care and the rise in venture capital investments is further driving the surge in demand for this technology.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

About Investorideas.com - Big Investing Ideas

Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors.

The Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.

Disclosure: GTCH is a paid featured AI stock on Investorideas. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com